Cordyceps Sunshine Biotech Holdings (RAJAF) EBITDA Margin (2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) posted quarterly EBITDA Margin of 38.18% for Q4 2023.

Cordyceps Sunshine Biotech Holdings (RAJAF) EBITDA Margin (2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' EBITDA Margin history runs 1 years deep, the most recent figure standing at 38.18% for Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Kraft Heinz	30.23 Bn	27.54 Bn	2.03 Bn	-102.70%
2	General Mills	21.36 Bn	20.90 Bn	1.60 Bn	-45.40%
3	Mccormick	14.89 Bn	14.56 Bn	778.20 Mn	14.27%
4	Jbs	14.54 Bn	11.07 Bn	4.91 Bn	2.38%
5	Hormel Foods	13.26 Bn	12.40 Bn	518.51 Mn	7.30%
6	J M Smucker	13.17 Bn	13.11 Bn	862.10 Mn	19.60%
7	Magnum Ice Cream	12.10 Bn	11.38 Bn	-	-
8	Darling Ingredients	10.78 Bn	10.62 Bn	503.37 Mn	32.20%
9	Smithfield Foods	8.77 Bn	7.42 Bn	478.00 Mn	7.84%
10	Cordyceps Sunshine Biotech Holdings	1.02 Bn	1.02 Bn	-	-

Download Data

Date	Value
Dec 31, 2023	38.18%